These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29268637)

  • 21. [Inhaled antibiotics for the management of non cystic fibrosis bronchiectasis].
    Berra G; Chappuis-Gisin É; Soccal PM; Plojoux J
    Rev Med Suisse; 2017 Nov; 13(583):2001-2004. PubMed ID: 29143505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled antibiotics in non-cystic fibrosis bronchiectasis: A meta-analysis.
    Xu L; Zhang F; Du S; Yu Q; Chen L; Long LH; Li YM; Jia AH
    Pharmazie; 2016 Sep; 71(9):491-498. PubMed ID: 29441843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bronchiectasis treatment in adults].
    Martínez García MA; Máiz Carro L; de Gracia Roldán J
    Med Clin (Barc); 2009 Sep; 133(11):433-40. PubMed ID: 19361821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis.
    Sibila O; Laserna E; Shoemark A; Keir HR; Finch S; Rodrigo-Troyano A; Perea L; Lonergan M; Goeminne PC; Chalmers JD
    Am J Respir Crit Care Med; 2019 Jul; 200(1):33-41. PubMed ID: 31109172
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK; Williams RW
    Respiration; 2014; 88(3):177-84. PubMed ID: 25171580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New and Current Concepts of Therapy in Non-CF Bronchiectasis].
    Allewelt M; de Roux A
    Dtsch Med Wochenschr; 2016 May; 141(10):694-9. PubMed ID: 27176062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhaled antibiotic therapy in bronchiectasis?].
    Kohlhäufl M; Scheuch G; Häussinger K
    Pneumologie; 2004 Jul; 58(7):499-504. PubMed ID: 15257472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.
    Masekela R; Green RJ
    Mediators Inflamm; 2012; 2012():134605. PubMed ID: 22570510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of bronchiectasis in adults.
    Visser SK; Bye P; Morgan L
    Med J Aust; 2018 Aug; 209(4):177-183. PubMed ID: 30107772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
    Chalmers JD; Smith MP; McHugh BJ; Doherty C; Govan JR; Hill AT
    Am J Respir Crit Care Med; 2012 Oct; 186(7):657-65. PubMed ID: 22744718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
    Visser SK; Bye PTP; Fox GJ; Burr LD; Chang AB; Holmes-Liew CL; King P; Middleton PG; Maguire GP; Smith D; Thomson RM; Stroil-Salama E; Britton WJ; Morgan LC
    Lung; 2019 Dec; 197(6):803-810. PubMed ID: 31691027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment adherence and health outcomes in patients with bronchiectasis.
    McCullough AR; Tunney MM; Quittner AL; Elborn JS; Bradley JM; Hughes CM
    BMC Pulm Med; 2014 Jul; 14():107. PubMed ID: 24980161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case reports of the treatment with tobramycin solution for inhalation in severe bronchiectasis patients continuous infection of Pseudomonas aeruginosa].
    Nakamura S; Yanagihara K; Morinaga Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2005 Jan; 43(1):41-7. PubMed ID: 15704452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis.
    Athanazio R; da Costa JC; de la Rosa Carrillo D; Martínez-García MÁ
    Expert Rev Respir Med; 2018 Jul; 12(7):569-584. PubMed ID: 29806511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchiectasis.
    McShane PJ; Tino G
    Chest; 2019 Apr; 155(4):825-833. PubMed ID: 30403962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
    Grimwood K; Bell SC; Chang AB
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.